These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 28042097

  • 1. Parkin deficiency accelerates consequences of mitochondrial DNA deletions and Parkinsonism.
    Song L, McMackin M, Nguyen A, Cortopassi G.
    Neurobiol Dis; 2017 Apr; 100():30-38. PubMed ID: 28042097
    [Abstract] [Full Text] [Related]

  • 2. Mutant Twinkle increases dopaminergic neurodegeneration, mtDNA deletions and modulates Parkin expression.
    Song L, Shan Y, Lloyd KC, Cortopassi GA.
    Hum Mol Genet; 2012 Dec 01; 21(23):5147-58. PubMed ID: 22949510
    [Abstract] [Full Text] [Related]

  • 3. Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease.
    Pinto M, Nissanka N, Moraes CT.
    J Neurosci; 2018 Jan 24; 38(4):1042-1053. PubMed ID: 29222404
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Endogenous Parkin Preserves Dopaminergic Substantia Nigral Neurons following Mitochondrial DNA Mutagenic Stress.
    Pickrell AM, Huang CH, Kennedy SR, Ordureau A, Sideris DP, Hoekstra JG, Harper JW, Youle RJ.
    Neuron; 2015 Jul 15; 87(2):371-81. PubMed ID: 26182419
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The Absence of Parkin Does Not Promote Dopamine or Mitochondrial Dysfunction in PolgAD257A/D257A Mitochondrial Mutator Mice.
    Scott L, Karuppagounder SS, Neifert S, Kang BG, Wang H, Dawson VL, Dawson TM.
    J Neurosci; 2022 Dec 07; 42(49):9263-9277. PubMed ID: 36280265
    [Abstract] [Full Text] [Related]

  • 8. Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations.
    Tzoulis C, Tran GT, Schwarzlmüller T, Specht K, Haugarvoll K, Balafkan N, Lilleng PK, Miletic H, Biermann M, Bindoff LA.
    Brain; 2013 Aug 07; 136(Pt 8):2393-404. PubMed ID: 23625061
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of parkin ameliorates dopaminergic neurodegeneration induced by 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Bian M, Liu J, Hong X, Yu M, Huang Y, Sheng Z, Fei J, Huang F.
    PLoS One; 2012 Aug 07; 7(6):e39953. PubMed ID: 22792139
    [Abstract] [Full Text] [Related]

  • 10. Mesencephalic complex I deficiency does not correlate with parkinsonism in mitochondrial DNA maintenance disorders.
    Palin EJ, Paetau A, Suomalainen A.
    Brain; 2013 Aug 07; 136(Pt 8):2379-92. PubMed ID: 23811324
    [Abstract] [Full Text] [Related]

  • 11. Dysregulation of parkin in the substantia nigra of db/db and high-fat diet mice.
    Khang R, Park C, Shin JH.
    Neuroscience; 2015 May 21; 294():182-92. PubMed ID: 25779963
    [Abstract] [Full Text] [Related]

  • 12. Progressive parkinsonism due to mitochondrial impairment: Lessons from the MitoPark mouse model.
    Beckstead MJ, Howell RD.
    Exp Neurol; 2021 Jul 21; 341():113707. PubMed ID: 33753138
    [Abstract] [Full Text] [Related]

  • 13. Parkin cooperates with GDNF/RET signaling to prevent dopaminergic neuron degeneration.
    Meka DP, Müller-Rischart AK, Nidadavolu P, Mohammadi B, Motori E, Ponna SK, Aboutalebi H, Bassal M, Annamneedi A, Finckh B, Miesbauer M, Rotermund N, Lohr C, Tatzelt J, Winklhofer KF, Kramer ER.
    J Clin Invest; 2015 May 21; 125(5):1873-85. PubMed ID: 25822020
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Parkin functionally interacts with PGC-1α to preserve mitochondria and protect dopaminergic neurons.
    Zheng L, Bernard-Marissal N, Moullan N, D'Amico D, Auwerx J, Moore DJ, Knott G, Aebischer P, Schneider BL.
    Hum Mol Genet; 2017 Feb 01; 26(3):582-598. PubMed ID: 28053050
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Detrimental effects of oxidative losses in parkin activity in a model of sporadic Parkinson's disease are attenuated by restoration of PGC1alpha.
    Siddiqui A, Rane A, Rajagopalan S, Chinta SJ, Andersen JK.
    Neurobiol Dis; 2016 Sep 01; 93():115-20. PubMed ID: 27185595
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.